Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Specific probiotics and virological findings in symptomatic conscripts attending military service in Finland.

  • 2014-07
  • Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 60(3)
    • Liisa Lehtoranta
    • Kim Kalima
    • Liang He
    • Maija Lappalainen
    • Merja Roivainen
    • Mervi Närkiö
    • Mika Mäkelä
    • Simo Siitonen
    • Riitta Korpela
    • Anne Pitkäranta

Study Design

Type
Randomized Controlled Trial (RCT)
Population
192 symptomatic conscripts
Methods
randomized, double-blind, placebo-controlled 90- and 150-day intervention study, daily chewable probiotic tablet containing Lactobacillus rhamnosus GG and Bifidobacterium animalis ssp. lactis BB-12 or control tablet
Blinding
Double-blind
Duration
90- and 150-day

Background

Viral upper respiratory tract infections occur frequently among conscripts. Probiotics have reduced viral infections in children attending day care. Limited data are available on the effects of probiotics on the nasopharyngeal presence of respiratory viruses.

Objectives

To assess, whether probiotics could decrease nasopharyngeal occurrence of respiratory viruses in Finnish conscripts.

Study design

In a randomized, double-blind, placebo-controlled 90- and 150-day intervention study, 239 nasopharyngeal swab samples were collected from 192 symptomatic conscripts receiving daily chewable probiotic tablet containing Lactobacillus rhamnosus GG and Bifidobacterium animalis ssp. lactis BB-12 (46.9%) or control tablet (53.1%) on visits to a garrison's health care center due to symptoms of infection. The presence of respiratory viruses was tested by PCR-methods, and viral findings were compared between the intervention groups.

Results

184 (76.9%) nasopharyngeal samples were positive for at least one respiratory virus. Picornaviruses were the most common viruses and were detected in 155 (84.2%) of samples. Of these, 143 (92.3%) were rhinovirus-positive and 20 (12.9%) were enterovirus-positive. The control group had 83 (64%) and the probiotic group 72 (66%) picornavirus infections (p=0.79). Monthly distribution of picornaviruses showed that there were less picornavirus findings after 3 months in the probiotic group than in the control group (p=0.0069). However, probiotics did not reduce picornavirus occurrence in other months.

Conclusions

Overall, probiotics did not reduce viral occurrence in symptomatic conscripts. However, probiotics decreased the presence of picornaviruses after 3 months, which may imply that probiotics play a role against viruses causing common cold. Further investigations are necessary to clarify the mechanisms involved in order to target specific probiotics on specific respiratory viruses.

Research Insights

    Back to top